GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (STU:DV3R) » Definitions » Debt-to-Asset

Delcath Systems (STU:DV3R) Debt-to-Asset : 0.01 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Delcath Systems Debt-to-Asset?

Delcath Systems's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €0.10 Mil. Delcath Systems's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €0.89 Mil. Delcath Systems's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was €73.14 Mil. Delcath Systems's debt to asset for the quarter that ended in Dec. 2024 was 0.01.

Delcath Systems Debt-to-Asset Historical Data

The historical data trend for Delcath Systems's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems Debt-to-Asset Chart

Delcath Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.48 0.89 0.26 0.01

Delcath Systems Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.24 0.17 0.10 0.01

Competitive Comparison of Delcath Systems's Debt-to-Asset

For the Medical Devices subindustry, Delcath Systems's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delcath Systems's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Delcath Systems's Debt-to-Asset falls into.


;
;

Delcath Systems Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Delcath Systems's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.1 + 0.891) / 73.142
=0.01

Delcath Systems's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.1 + 0.891) / 73.142
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delcath Systems  (STU:DV3R) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Delcath Systems Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Delcath Systems's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Delcath Systems Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (STU:DV3R) » Definitions » Debt-to-Asset
Comparable Companies
CLPT TMCI SRDX LAB NPCE VREX SMLR TCMD NNOX BBNX ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
DCTH:USA DV3R:Germany
Address
566 Queensbury Avenue, Queensbury, NY, USA, 12804
Website
https://www.delcath.com
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Delcath Systems Headlines

No Headlines